Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Zoann E. Dreyer, MD
Texas Children's Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
140 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- Children'S & Women'S Hospital of British Columbia
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Montreal Children'S Hospital at Mcgill University Health Center
Montreal, Quebec, Canada
- Allan Blair Cancer Centre at Pasqua Hospital
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre at the University of Saskatchewan
Saskatoon, Saskatchewan, Canada
- Swiss Pediatric Oncology Group Bern
Bern, Switzerland
- Swiss Pediatric Oncology Group Geneva
Geneva, Switzerland
- Swiss Pediatric Oncology Group Lausanne
Lausanne, Switzerland
- Comprehensive Cancer Center at University of Alabama at Birmingham
Birmingham, Alabama, United States
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Southern California Permanente Medical Group
Downey, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center
Loma Linda, California, United States
- Jonathan Jaques Children'S Cancer Center at Miller Children'S Hospital
Long Beach, California, United States
- Children'S Hospital Central California
Madera, California, United States
- Children'S Hospital and Research Center - Oakland
Oakland, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Kaiser Permanente Medical Center - Oakland
Sacramento, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- Children'S Hospital and Health Center - San Diego
San Diego, California, United States
- Ucsf Comprehensive Cancer Center
San Francisco, California, United States
- Santa Barbara Cottage Children'S Hospital
Santa Barbara, California, United States
- Stanford Cancer Center at Stanford University Medical Center
Stanford, California, United States
- Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center
Farmington, Connecticut, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Broward General Medical Center Cancer Center
Fort Lauderdale, Florida, United States
- Lee Cancer Care of Lee Memorial Health System
Fort Myers, Florida, United States
- University of Florida Shands Cancer Center
Gainesville, Florida, United States
- Nemours Children'S Clinic
Jacksonville, Florida, United States
- Baptist-South Miami Regional Cancer Program
Miami, Florida, United States
- Florida Hospital Cancer Institute at Florida Hospital Orlando
Orlando, Florida, United States
- Nemours Children'S Clinic - Orlando
Orlando, Florida, United States
- Sacred Heart Cancer Center at Sacred Heart Hospital
Pensacola, Florida, United States
- St. Joseph'S Cancer Institute at St. Joseph'S Hospital
Tampa, Florida, United States
- Kaplan Cancer Center at St. Mary'S Medical Center
West Palm Beach, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 1996
- Primary completion
- 30 Sept 2007
- Completion
- 31 Mar 2012
- Last update posted
- 14 Feb 2014
- Registered enrollment
- 221
- Registry id
- NCT00002756
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.